Financials in USD. Standardized financial statements.
A compact view of how China Medical & HealthCare Group Limited turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.63B | $1.57B | $1.44B | $1.48B | $1.21B | $1.25B | $1.20B | $1.11B | $1.49B | $2.40B |
| Revenue Growth? | +3.7% | +9.0% | -2.6% | +21.6% | -2.8% | +4.5% | +7.7% | -25.7% | -37.7% | 0.0% |
| Cost of Revenue? | $1.30B | $1.28B | $1.28B | $1.30B | $1.09B | $1.09B | $950.07M | $927.38M | $1.00B | $2.26B |
| Gross Profit? | $324.55M | $286.22M | $161.87M | $175.97M | $124.91M | $158.24M | $245.75M | $182.72M | $490.50M | $136.73M |
| Gross Margin? | +19.9% | +18.2% | +11.2% | +11.9% | +10.3% | +12.7% | +20.6% | +16.5% | +32.8% | +5.7% |
| Operating Expenses? | $238.44M | $203.01M | $201.12M | $197.03M | $137.86M | $214.55M | $241.41M | $248.06M | $237.90M | $223.97M |
| Operating Income? | $86.12M | $83.21M | -$39.26M | -$21.06M | -$12.95M | -$1.39M | $16.49M | -$74.79M | $80.84M | $49.84M |
| EBITDA? | $183.43M | $174.83M | $46.54M | $52.31M | $69.79M | $70.81M | $16.49M | $31.28M | $139.16M | -$750.65M |
| Income Before Tax | $57.00M | $35.40M | -$117.17M | -$110.47M | -$96.56M | $105.18M | -$13.62M | $106.07M | $99.85M | -$774.65M |
| Income Tax Expense | $15.03M | $14.91M | $1.98M | $16.80M | $8.58M | $122.67M | -$50.23M | $44.98M | $378.76M | $115.65M |
| Net Income? | $28.77M | $11.29M | -$123.57M | -$137.30M | -$111.93M | $17.49M | $34.89M | -$61.09M | $278.90M | -$783.16M |
| EPS? | $0.03 | $0.01 | $-0.17 | $-0.19 | $-0.15 | $-19207429.00 | $0.05 | $0.45 | $-3.88 | $-1.24 |
| Diluted EPS? | $0.03 | $0.01 | $-0.17 | $-0.19 | $-0.15 | $-25740795.00 | $0.05 | $325114422.00 | $-2820060667.34 | $-1.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality